Obesity and GLP-1s in Everyday Practice: What Every Clinician Needs to Know, NHS and Private
Get up to date with obesity and GLP-1 medicines, and find out how the Bodyline referral pathway can support patients with more complex weight-health needs.
Join this free, one-hour webinar for GP practice teams and community pharmacy. Sobia Arshad will cover NHS eligibility and private access, safe titration, red flags and stopping treatment. Dr Morgan Toerien will explain how the Bodyline pathway works, which patients may be suitable for referral and what happens next.
Bring your questions to the live discussion.
Free to attend. No obligation. Book your place today.
See Sponsors below
£0.00
Obesity and GLP-1s in Everyday Practice
What every clinician needs to know, NHS and private
A practical update on obesity management and weight-loss medicines for
GP practices and community pharmacy teams, followed by an introduction to the
Bodyline referral pathway for patients with more complex weight-health needs.
For GP practice teams and community pharmacy
Patients are asking about weight-loss injections every day. Are you ready for the conversation?
GLP-1 based medicines have changed the way obesity is treated. Patients now arrive at the surgery
and the pharmacy counter with questions about NHS eligibility, private prescriptions, side effects and what happens when they stop.
Many are already using these medicines, some bought online, and not all of them are suitable for the services available locally.
This webinar gives your team the knowledge and the onward route to respond with confidence.
You will get a clear clinical update on obesity and GLP-1 therapy in primary care, and find out how the Bodyline referral pathway can support patients whose needs sit outside your own service.
Learn
Update your knowledge of obesity as a long-term condition and the GLP-1 medicines now used to treat it.
Refer
Find out how the Bodyline pathway gives eligible patients a clear onward route to specialist care.
Support
Help patients get safe, supervised support for more complex weight-health needs.
What does the webinar cover?
Part one :Learning about Bodyline
- Who Bodyline is and how its clinical service is delivered
- Which patients may be suitable for referral
- How GP practices and community pharmacies can refer
- What happens to the patient after referral
Part two: Obesity and GLP-1s in everyday practice
- Obesity as a chronic, relapsing condition and why it matters in primary care
- How GLP-1 and dual agonist medicines work, and what outcomes patients can expect
- NHS eligibility, current NICE guidance and how NHS and private routes differ
- Safety essentials: side effects, contraception, pregnancy, interactions and when to seek advice
- Spotting risk with medicines bought online or from unregulated sources
- Stopping treatment, weight regain and supporting long-term maintenance
Specialist weight-health support with 18 years of experience
Bodyline is a specialist CQC-regulated weight-loss clinic group with 18 years of experience delivering supported weight-loss programmes, including enhanced clinical support options for patients who need closer supervision.
With 7 clinics across the North West and UK-wide video consultations, Bodyline provides personalised, evidence-based care to help patients improve and maintain their weight health.
What you will gain
|
✓
|
Confidence with GLP-1 conversationsAnswer common patient questions about weight-loss medicines clearly and safely. |
|
✓
|
Clarity on NHS and private routesUnderstand who is eligible for what, and how to guide patients through the options. |
|
✓
|
Safer practiceRecognise key safety issues and know when a patient needs further review or advice. |
|
✓
|
A clear onward routeLearn how the Bodyline pathway works and which patients may be suitable for referral. |
|
✓
|
Time for your questionsBring your real-world cases and questions to a live discussion. |
Who should attend?
This webinar is designed for primary care teams, including:
- GPs and GP registrars
- Practice nurses and advanced nurse practitioners
- PCN and practice clinical pharmacists
- Community pharmacists, pharmacy owners and contractors
- Superintendent pharmacists and pharmacy leaders involved in weight-management services
It is ideal for anyone who talks to patients about weight, supports patients taking GLP-1 medicines,
or wants a trusted referral route for patients with more complex needs.
Why attend now?
Demand for weight-management support is rising fast, and GLP-1 medicines are now part of everyday conversations in both general practice and community pharmacy.
NHS access is expanding in phases, private supply continues to grow, and patients often move between the two. Clinicians need to be confident about what is safe, what is appropriate and where to send patients next.
Practices and pharmacies with up-to-date knowledge and a trusted referral route are better placed to protect patient safety and keep the relationship with people who come to them for help.
The aim is simple: know the facts, have the conversation and give every patient a clear next step.
This webinar is supported by Bodyline.
WEBINAR
THIS EVENT IS OPEN TO UK REGISTERED HEALTHCARE PROFESSIONALS ONLY
Location: MS Teams
Event Agenda
| Time | Topic | Speaker |
|---|---|---|
| 19:00-19:05 | Introduction | CliniLink |
| 19:05-19:35 | Learning about Bodyline: who Bodyline is, which patients may be suitable for referral and how GP practices and community pharmacies can refer | Dr Morgan Toerien- Clinical Director, Bodyline Clinic |
| 19:35-20:20 | Obesity and GLP-1s in Everyday Practice You will learn how to: Explain NHS eligibility against private access clearly to patients Titrate doses safely and manage GI side effects Spot the red flags Support patients who bought privately or online and now present to you Plan for stopping treatment and preventing weight regain | Dr Sobia Arshad |
Meet the Speakers
Dr Morgan Toerien
MBChB, Clinical Director, Bodyline ClinicDr Sobia Arshad
Dr Sobia Arshad
Consultant Endocrinologist
Dr Sobia Arshad is a Consultant Endocrinologist with broad experience in endocrinology, diabetes and metabolic medicine. She practises at The Blackheath Hospital, The Sloane Hospital and LycaHealth Orpington. Her particular clinical interests are obesity, thyroid disorders and lipid management, and she has a special focus on obesity medicine and the rapidly evolving range of treatment options now available to patients.
Alongside her clinical practice, Dr Arshad is committed to medical education. She holds a permanent post as Associate Lecturer at Kent and Medway Medical School, where she teaches Year 2 medical students. She is also actively involved in postgraduate education for GPs, organising and delivering sessions in collaboration with hospitals and healthcare organisations, as well as through webinars and wider teaching programmes.
Obesity medicine is a central theme of her teaching. As novel pharmacological treatments continue to emerge, she helps clinicians understand the evidence, appropriate patient selection, practical use, monitoring and potential adverse effects of these therapies, translating complex and evolving evidence into clear guidance for everyday practice.
Dr Arshad is highly regarded by students and healthcare professionals alike for her clear explanations, approachable style and ability to make complex subjects engaging and clinically relevant.
Educational Partner
